A real life multicenter national study on the use of nintedanib in moderate to severe IPF patients

A. Caminati (Milano, MI, Italy)

Source: International Congress 2017 – IPF: from the bench to the bedside
Session: IPF: from the bench to the bedside
Session type: Thematic Poster
Number: 3816
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Caminati (Milano, MI, Italy). A real life multicenter national study on the use of nintedanib in moderate to severe IPF patients. 3816

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of tele healthcare on quality of life in patients with severe COPD: a randomized clinical trial
Source: International Congress 2017 – Best abstracts in physical activity and management of COPD
Year: 2017

Quality of diffusion measurement in a multicenter clinical trial with moderate to severe COPD patients with emphysema
Source: Annual Congress 2010 - Quality measurement and improvement in lung function
Year: 2010


A multicentre, observational cohort study to determine the efficacy and safety of lumacaftor/ivacaftor in patients with severe lung disease and cystic fibrosis
Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis
Year: 2019



Edu-Care®, a randomised, multicentre study on education and quality of life in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 211s
Year: 2002

Quality of forced spirometry in a worldwide multicenter clinical trial with moderate to severe COPD patients with emphysema
Source: Annual Congress 2010 - Quality measurement and improvement in lung function
Year: 2010


PEGASUS - the effects of commercial air travel on patients suffering from pulmonary hypertension - a prospective, multicenter, multinational study
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018

Short-term HRQL deterioration during early-phase COPD exacerbation: a prospective Canadian cohort study
Source: Eur Respir J 2005; 26: Suppl. 49, 296s
Year: 2005

An international prospective cohort study to develop a practical COPD disease risk index that predicts the clinical course of COPD
Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care
Year: 2009

Neomacrolides in the treatment of patients with severe asthma and/or bronchiectasis: A retrospective observational study
Source: Annual Congress 2010 - Aspects of severe asthma
Year: 2010


Real-world exacerbation rates in Japanese patients with COPD: results from the EXACOS observational cohort study
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021


Tiotropium discontinuation in patients with early-stage COPD: a prospective observational cohort study
Source: ERJ Open Res, 5 (1) 00175-2018; 10.1183/23120541.00175-2018
Year: 2019



Evidence generation for the clinical impact of myCOPD in patients with mild, moderate and newly diagnosed COPD: a randomised controlled trial
Source: ERJ Open Res, 6 (4) 00460-2020; 10.1183/23120541.00460-2020
Year: 2020



How far is real life from COPD therapy guidelines? An observational study on 4000 patients in Italy
Source: Annual Congress 2010 - Management of airway disease
Year: 2010

Tofacitinib versus standard of care treatment in patients with COVID-19 pneumonia and respiratory failure: a multicenter cohort study
Source: Virtual Congress 2021 – Acute COVID - 19
Year: 2021



Progression of physical inactivity in COPD patients: the effect of time and climate conditions – a multicentre prospective cohort study
Source: International Congress 2019 – Hot topics in pulmonary rehabilitation
Year: 2019

Preliminary results of a prospective cohort study on the risk of depression in patients with COPD in general practice
Source: Eur Respir J 2005; 26: Suppl. 49, 673s
Year: 2005

The long-term clinical and economic impact of COPD exacerbations: an observational study (SHERLOCK)
Source: Virtual Congress 2020 – Prediction and management of outcomes in obstructive diseases
Year: 2020




Real-life effectiveness of omalizumab in difficult-to-treat versus severe asthma: a national cohort study in Belgium
Source: ERJ Open Res, 5 (4) 00253-2018; 10.1183/23120541.00253-2018
Year: 2019



Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study
Source: Eur Respir J 2010; 35: 532-539
Year: 2010



Spanish study on unmet clinical needs in patients with uncontrolled severe asthma.
Source: International Congress 2018 – Asthma management
Year: 2018